10/1/21 – Medicoil, a division of R&L Spring Company, announced that it has broken ground for a 40,000-sq-ft expansion to its facility in Lake Geneva, Wisconsin.

A press release said that the new manufacturing space is scheduled for completion in early 2022 and will support their continued growth in the medical device market. “For the fourth time since 1997 we are again proud to expand our manufacturing business,” said company owner and President Scott Forsythe.

Per its website, Medicoil was formed in 1992, a division of R&L Spring Company, which began in 1972. It supplies precision springs and wireforms to a wide range of OEMs in powersports, automotive, medical, and other general industries markets. The Medicoil brand was established in 2000 to focus on opportunities in the medical market. It has preferred-supplier status among some of the world’s leading medical device companies for its prevision coiled and formed wire products that are used in components and subassemblies that go into implantable devices. Medicoil’s modern facilities include an ISO 7 (Class 10,000) Clean Room.

R&L Spring Company notes that it is a preferred source of OEMs for precision springs, rings, wireforms and four-slide components, plus secondary and finishing processes.

10/1/21 – Nexans announced that it has entered into a share purchase agreement with Xignux SA of Mexico to acquire Centelsa, a premium cable maker in Latin America, for an undisclosed price.

A press release said that Centelsa, based in Colombia, produces cable for building and utilities applications. It was described as an “iconic world class cable maker,” with annual revenues of more than US$250 million and an enterprise value of US$225 million. The closing, subject to regulatory approvals, is expected to take place in the first half of 2022.

The Centelsa acquisition “is fully aligned with (our) strategic ambition to become a pure electrification player,” said Nexans CEO Christopher Guérin. The addition will further contribute to Nexans’s ability to serve renewable projects in the Andean Region and enhance its capacity in building and energy distribution.

“This combination will be the stepstone to grow our best-in-class solutions and unique premium brand,” said Viakable-Centelsa CEO Sergio Valdes. “The Centelsa team has demonstrated, for more than six decades, professionalism in delivering high value to our customers. As a global player in energy transmission, Nexans is a great fit to lead the next phase of growth for Centelsa´s customers and employees. Jointly, there is a promising future ahead.”

Centelsa was cited as being the first cable manufacturer in Colombia. Per Centelsa’s website, the company’s origin traces back to 1955, when INCE Ltda (Industria Nacional de Conductores Eléctricos) started its operation in the city of Cali, manufacturing low-voltage cables as magnet wire for applications in motor winding. In 1961, Ceat General of Colombia S.A. was established through the merger with U.S.-based General Cable Corporation and Italy’s Ceat International. It expanded in 1980 with a second plant, then a third in 1993. In 1994, CENTELSA (Cables De Energia Y Telecomunicaciones S.A.) was formed by the merger of Ceat General De Colombia S.A., Facomec and Fadaltec S.A. In 2012, it became part of the Viakable, the cables division of Xignux, a Mexican industrial group.

Over the years, Centelsa won numerous awards and certifications. Today, it has a network of strategically located offices to cover the national and international market, thus offering an opportune service.

9/8/21 -- Following a recent order for a new wire rod outlet, Primetals Technologies has been contracted by Kaptan Demir Çelik (Kaptan Iron & Steel) to supply the upstream mill for the Marmara Ereğlisi, Turkey production site.

A press release said that the mill will prepare the round feedstocks (intermediate sizes) to be further rolled and finished in the wire rod outlet. It will have a yearly capacity of 650,000 metric tons. High-value products will be processed such as carbon, SBQ and austenitic stainless-steel grades, catering to the engineering and automotive industries in both domestic and export markets. The hot commissioning of the complete installation is expected in mid-2022.

The upstream mill will have a maximum rolling rate of 130 tons per hour, and will process billets with square dimensions of 130, 160 and 200 mm and length of 12 meters. The diameters of the prepared feedstocks will range from 17 mm to 33 mm, as required by the roll pass design of the wire rod outlet. The layout, equipment and process of the new upstream mill will be optimized and compatible with an additional bar outlet to be added later, which will make the installation a modern combined mill of quality and austenitic stainless steel.

In other news, Bosnian steel producer ArcelorMittal Zenica d.o.o. placed an order with Primetals Technologies to replace the vessel of BOF converter #2 and supply associated equipment. An optimized design will increase the vessel volume and make production easier. ArcelorMittal Zenica is the largest producer of long steel products in the Balkans with annual production capacity of nearly one million tons per year. The company’s base product range includes rebar (in bars and coils), wire rod, mesh and lattice girders.

9/8/21 -- Central Wire President Paul From recently announced that all company employees would be required to be vaccinated by Oct. 29, barring an acceptable exemption request. Below, he shares further thoughts on this with WJI.

WJI: Just how many people does this edict cover, and what has the response been so far?
From: It covers everyone, which is approximately 700 people in 13 facilities in the U.S., U.K. and Canada. I have been overwhelmed with the positive response from employees. It surprised me. There have been some negative calls but many more positive ones. My contact info is posted in all the plants, so anyone can call me to discuss this—good, bad or indifferent—and they do. I have had some interesting conversations with people who felt that they could not speak out in favor of the vaccine inside the facility because some people would get angry. They remained uncommitted and confused about what to do. There was a lot of disinformation being pushed around and politicized, and I suspect that’s commonplace in many companies.

WJI: You didn’t have to do this, so why are you?
From: I am treating this as a health and safety threat. As president and CEO, it’s a lot easier if I apply the science and technology we would use to deal with any workplace hazard. As a virus, it can be stopped, and my job is to stop it. I have to provide the safest workplace I can, that’s my role.

WJI: Are you getting any calls from other manufacturers?
From: As of yesterday, 15, and they all are moving in this direction. All were very concerned about the ramifications but feel this is the way to go.

WJI: Could there be a legal challenge to this by employees?
From: That’s a good question. Yes, there could be, but it could be from both sides, the unvaccinated and the vaccinated. Anyone can hire a lawyer. The unvaccinated can fight it, but the courts seem already to have moved in a firm direction on this. The vaccinated can also demand companies take action to guarantee a safe workplace. I think that is just around the corner actually, and I want to be in front of it. If I can’t provide a safe work environment for the vaccinated, they have every right to challenge us. Should the virus have the capacity to mutate again, and it becomes even more transmissible and deadly, then the situation will change again. I would prefer to deal with this entire situation before that can happen.

WJI: Is your edict the same for all your operations?
From: Yes. Rules for Canada and the U.K. are somewhat different than the U.S., but what we are doing is still fine. The Canadian government just mandated vaccines for all federal employees, air travelers, train travelers and over-night vessel travelers.

WJI: What would you like to say to employees who oppose this?
From: Think of your coworkers. I know of six employees undergoing cancer treatment in our company, and I am sure there are others who have family members facing the same thing. I know of employees whose children have either received organ transplants or have disabilities and health challenges that even without Covid must be hard to cope with. We also have employees who have diabetes and other conditions that compromised their immune systems. Do you really want to expose them to this risk?
That also goes for other company owners: do you want someone inside your factory to become infected and take it home to someone not strong enough to fight this?
Freedom of choice I understand, but it goes hand in hand with a greater responsibility. Thankfully we have a number of vaccine choices. We must protect the integrity of our health care system and the professionals who are fighting a minute-by-minute battle to keep people alive.

WJI: How has this situation affected your business?
From: I was born in 1965, and this is my first pandemic. It is a struggle unlike anything I have ever experienced. There is no playbook for this. The last 18 months have been a huge struggle. I spend little time running the business in the traditional sense, buying equipment, considering acquisitions, seeing customers and suppliers, improving operations and developing a better future. I had expected that once the vaccine came out, it would greatly improve things and allow us to get back to “normal.” Now I feel further from normal than ever, but I also believe that the companies that can get past this will have achieved something great, and by doing so they will have benefitted employees, shareholders and society. I truly believe that.